Showing results (171-180 of 232) with videos related to
Sort By:
Pageof 24
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 11, 1998
Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8L L Reznikov, A J Puren, G Fantuzzi, et al.Current Medical Research and Opinion|June 18, 2004
Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatinTeddy Kosoglou, Paul Statkevich, Ingo Meyer, et al.Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|June 3, 2016
A Qualitative Study of Factors Affecting Morale in Psychiatry Residency TrainingRachel A Caravella, Lee A Robinson, Ilene Wilets, et al.Journal of Applied Biomechanics|July 11, 2018
Gait Mechanics Differences Between Healthy Controls and Patients With Peripheral Artery Disease After Adjusting for Gait Velocity Stride Length and Step WidthJohn D McCamley, Eric L Cutler, Kendra K Schmid, et al.Advances in Health Sciences Education : Theory and Practice|September 4, 2008
Discrediting the notion "working with 'crazies' will make you 'crazy'": addressing stigma and enhancing empathy in medical student educationJanis L Cutler, Kelli J Harding, Sharon A Mozian, et al.Blood|January 15, 1996
Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteersR D Huhn, E Radwanski, S M O'Connell, et al.Pharmaceutical Research|January 6, 2001
Population pharmacokinetics of temozolomide in cancer patientsJ F Jen, D L Cutler, S M Pai, et al.European Journal of Clinical Pharmacology|April 25, 2012
Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairmentPaul Statkevich, Teddy Kosoglou, Richard A Preston, et al.Chronobiology International|March 11, 1998
The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to lightA J Lewy, V K Bauer, S Ahmed, et al.Journal of Clinical Pharmacology|September 1, 1995
Oral and intravenous zidovudine pharmacokinetics: the effect of granulocyte-macrophage colony stimulating factorF T Aweeka, M Mak, A al-Uzri, et al.Pageof 24